Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

A repeated short educational intervention improves asthma control and quality of life
Plaza V, Peiro M, Torrejon M, Fletcher M, Lopez-Vina A, Ignacio JM, Quintano JA, Bardagi S, Gich I, on behalf of the Prometheus Study Group
The European Respiratory Journal 2015 Nov;46(5):1298-1307
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

We assessed the effectiveness of an asthma educational programme based on a repeated short intervention (AEP-RSI) to improve asthma control (symptom control and future risk) and quality of life. A total of 230 adults with mild-to-moderate persistent uncontrolled asthma participated in a 1-year cluster randomised controlled multicentre study. The AEP-RSI was given in four face-to-face sessions at 3-month intervals, and included administration of a written personalised action plan and training on inhaler technique. Centres were randomised to the AEP-RSI (intervention) group or usual clinical practice group. Specialised centres using a standard educational programme were the gold standard group. A significant improvement in the Asthma Control Test score was observed in all three groups (p < 0.001), but improvements were higher in the intervention and gold standard groups than in the usual clinical practice group (p = 0.042), which also showed fewer exacerbations (mean +/- SD 1.20 +/- 2.02 and 0.56 +/- 1.5 versus 2.04 +/- 2.72, respectively) and greater increases in the Mini Asthma Quality of Life Questionnaire scores (0.95 +/- 1.04 and 0.89 +/- 0.84 versus 0.52 +/- 0.97, respectively). The AEP-RSI was effective in improving asthma symptom control, future risk and quality of life.
Permission granted by European Respiratory Society Journals Ltd.

Full text (sometimes free) may be available at these link(s):      help